Profound Medical Corp Stock Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
May. 15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Sales 2024 * | 15.49M 11.29M | Sales 2025 * | 41.61M 30.32M | Capitalization | 271M 197M |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.15M | Net income 2025 * | -31M -22.59M | EV / Sales 2024 * | 17.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.51 x |
P/E ratio 2024 * |
-6.94
x | P/E ratio 2025 * |
-7.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.1% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
1st Jan change | Capi. | |
---|---|---|
+6.82% | 218B | |
+10.06% | 189B | |
+27.79% | 151B | |
+32.15% | 113B | |
-0.15% | 64.02B | |
+14.20% | 52.6B | |
+1.85% | 49.85B | |
-5.64% | 37.89B | |
+0.54% | 34.92B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock